Harvard Bioscience, Inc. - stock earnings
HBIO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 BeforeMarket | - / 0.0200000000 | - | - / 25.8 million | - |
HBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.8 million USD | 28.2 million USD |
| 2023Q3 | -1.2 million USD | 25.4 million USD |
| 2023Q2 | -980000 USD | 28.8 million USD |
| 2023Q1 | 622000 USD | 30.0 million USD |
| 2022Q4 | -1.7 million USD | 28.4 million USD |
| 2022Q3 | -3.4 million USD | 26.9 million USD |
| 2022Q2 | 2.4 million USD | 29.2 million USD |
| 2022Q1 | -6.9 million USD | 28.8 million USD |
| 2021Q4 | 961000 USD | 33.1 million USD |
| 2021Q3 | -170000 USD | 29.7 million USD |
| 2021Q2 | -410000 USD | 29.2 million USD |
| 2021Q1 | -669000 USD | 27.0 million USD |
| 2020Q4 | -615000 USD | 31.0 million USD |
| 2020Q3 | -1.1 million USD | 24.0 million USD |
| 2020Q2 | -1.6 million USD | 23.3 million USD |
| 2020Q1 | -4.5 million USD | 23.8 million USD |
| 2019Q4 | -4.7 million USD | 116.2 million USD |
| 2019Q3 | -2.6 million USD | 27.4 million USD |
| 2019Q2 | -247000 USD | 29.6 million USD |
| 2019Q1 | -2.4 million USD | 28.2 million USD |
| 2018Q4 | 2.3 million USD | 33.9 million USD |
| 2018Q3 | -256000 USD | 28.6 million USD |
| 2018Q2 | -1.5 million USD | 31.5 million USD |
| 2018Q1 | -4.1 million USD | 26.8 million USD |
| 2017Q4 | 999000 USD | 27.5 million USD |
| 2017Q3 | -417000 USD | 25.1 million USD |
| 2017Q2 | -381000 USD | 25.2 million USD |
| 2017Q1 | -1.1 million USD | 24.2 million USD |
| 2016Q4 | -1.3 million USD | 26.4 million USD |
| 2016Q3 | -1.6 million USD | 25.0 million USD |
| 2016Q2 | -713000 USD | 26.1 million USD |
| 2016Q1 | -17.1 million USD | 28.4 million USD |
| 2015Q4 | -17.1 million USD | 28.4 million USD |
| 2015Q3 | -847000 USD | 25.7 million USD |
| 2015Q2 | 349000 USD | 28.8 million USD |
| 2015Q1 | -1.4 million USD | 25.8 million USD |
| 2014Q4 | -19000 USD | 30.4 million USD |
| 2014Q3 | 633000 USD | 25.4 million USD |
| 2014Q2 | 1.0 million USD | 27.0 million USD |
| 2014Q1 | 719000 USD | 25.9 million USD |
| 2013Q4 | -756000 USD | 27.9 million USD |
| 2013Q3 | -983000 USD | 25.1 million USD |
| 2013Q2 | -186000 USD | 26.1 million USD |
| 2013Q1 | 96000 USD | 26.1 million USD |
| 2012Q4 | 1.2 million USD | 28.2 million USD |
| 2012Q3 | -133000 USD | 26.1 million USD |
| 2012Q2 | 774000 USD | 28.5 million USD |
| 2012Q1 | 529000 USD | 28.3 million USD |
| 2011Q4 | 738000 USD | 29.0 million USD |
| 2011Q3 | 28000 USD | 26.4 million USD |
| 2011Q2 | 1.4 million USD | 27.1 million USD |
| 2011Q1 | 1.7 million USD | 26.3 million USD |
| 2010Q4 | 2.2 million USD | 29.5 million USD |
| 2010Q3 | 12.7 million USD | 26.5 million USD |
| 2010Q2 | 1.9 million USD | 25.9 million USD |
| 2010Q1 | 2.2 million USD | 26.3 million USD |
| 2009Q4 | 3.8 million USD | 27.7 million USD |
| 2009Q3 | 1.3 million USD | 21.0 million USD |
| 2009Q2 | 281000 USD | 18.0 million USD |
| 2009Q1 | 1.8 million USD | 19.1 million USD |
| 2008Q4 | 2.1 million USD | 23.1 million USD |
| 2008Q3 | 1.4 million USD | 20.0 million USD |
| 2008Q2 | -2.2 million USD | 23.0 million USD |
| 2008Q1 | 687000 USD | 22.0 million USD |
| 2007Q4 | -1.3 million USD | 24.5 million USD |
| 2007Q3 | 1.2 million USD | 19.4 million USD |
| 2007Q2 | -1.8 million USD | 20.4 million USD |
| 2007Q1 | 496000 USD | 19.1 million USD |
| 2006Q4 | -2.4 million USD | 21.7 million USD |
| 2006Q3 | -179000 USD | 18.9 million USD |
| 2006Q2 | -324000 USD | 18.2 million USD |
| 2006Q1 | 540000 USD | 17.4 million USD |
| 2005Q4 | -5.4 million USD | 17.8 million USD |
| 2005Q3 | 661000 USD | 17.2 million USD |
| 2005Q2 | -27.4 million USD | 21.7 million USD |
| 2005Q1 | 202000 USD | 22.4 million USD |
| 2004Q4 | 1.1 million USD | 24.7 million USD |
| 2004Q3 | 957000 USD | 23.2 million USD |
| 2004Q2 | 298000 USD | 22.5 million USD |
| 2004Q1 | -51000 USD | 22.2 million USD |
| 2003Q4 | 1.8 million USD | 24.2 million USD |
| 2003Q3 | 986000 USD | 21.1 million USD |
| 2003Q2 | 743000 USD | 22.4 million USD |
| 2003Q1 | 776000 USD | 19.5 million USD |
| 2002Q4 | -971673 USD | 18.9 million USD |
| 2002Q3 | -82000 USD | 12.8 million USD |
| 2002Q2 | 1.0 million USD | 13.7 million USD |
| 2002Q1 | -434418 USD | 11.9 million USD |
| 2001Q4 | -434418 USD | 11.9 million USD |
| 2001Q3 | 319000 USD | 10.6 million USD |
| 2001Q2 | -5.4 million USD | 9.7 million USD |
| 2001Q1 | 34.0 million USD | 8.5 million USD |
| 2000Q4 | 34.0 million USD | 8.5 million USD |
| 2000Q3 | -28.0 million USD | 7.4 million USD |
| 2000Q2 | -28.0 million USD | 7.4 million USD |
| 2000Q1 | -28.0 million USD | 7.4 million USD |
HBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -3.4 million USD | 112.3 million USD |
| 2022 | -9.5 million USD | 113.3 million USD |
| 2021 | -288000 USD | 118.9 million USD |
| 2020 | -7.8 million USD | 102.1 million USD |
| 2019 | -4.7 million USD | 116.2 million USD |
| 2018 | -3.5 million USD | 120.8 million USD |
| 2017 | -865000 USD | 101.9 million USD |
| 2016 | -4.3 million USD | 104.5 million USD |
| 2015 | -19.0 million USD | 108.7 million USD |
| 2014 | 2.4 million USD | 108.7 million USD |
| 2013 | -1.8 million USD | 105.2 million USD |
| 2012 | 2.4 million USD | 111.2 million USD |
| 2011 | 3.8 million USD | 108.9 million USD |
| 2010 | 19.0 million USD | 108.2 million USD |
| 2009 | 7.2 million USD | 85.8 million USD |
| 2008 | 1.7 million USD | 88.0 million USD |
| 2007 | -1.4 million USD | 83.4 million USD |
| 2006 | -2.3 million USD | 76.2 million USD |
| 2005 | -31.9 million USD | 67.4 million USD |
| 2004 | 2.3 million USD | 92.6 million USD |
| 2003 | 4.3 million USD | 87.1 million USD |
| 2002 | 737327 USD | 57.4 million USD |
| 2001 | -5.2 million USD | 40.9 million USD |
| 2000 | -49.9 million USD | 30.6 million USD |
| 1999 | -29.4 million USD | 26.2 million USD |
| 1998 | 71000 USD | 12.2 million USD |
HBIO
Price: $3.85
52 week price:
Earnings Per Share: -0.08 USD
P/E Ratio: -59.13
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 13674
Ebitda: 836000Market Capitalization: 167.2 million